Menopause is known as the end of the female reproductive period and usually occurs in nearly 85% of women at the age of 40. Menopause leads to a decrease in estrogen and an increase in gonadotropins, leading to a cessation of the menstrual cycle and menstrual flow. These physiological changes lead to vasomotor symptoms. Vasomotor symptoms are a transition between the two phases of menopause and menopause.
This report elaborates the market size, market characteristics, and market growth of the Vasomotor Symptoms of Menopause Treatment industry, and breaks down according to the type, application, and consumption area of Vasomotor Symptoms of Menopause Treatment. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Vasomotor Symptoms of Menopause Treatment in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Vasomotor Symptoms of Menopause Treatment market covered in Chapter 13:
MenoGeniX, Inc.
Pivot Pharmaceuticals Inc
Pherin Pharmaceuticals, Inc.
Amgen Inc.
Euroscreen S.A.
Mithra Pharmaceuticals S.A.
TherapeuticsMD, Inc.
Radius Health, Inc.
EndoCeutics, Inc.

In Chapter 6, on the basis of types, the Vasomotor Symptoms of Menopause Treatment market from 2015 to 2025 is primarily split into:
Estetrol
Fezolinetant
FP-101
HBN-2
Others

In Chapter 7, on the basis of applications, the Vasomotor Symptoms of Menopause Treatment market from 2015 to 2025 covers:
Hospital
Homecare
Clinic

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025